BenQ BM Holding Cayman (2581) H1 2026 earnings summary

Executive summary

• H1 2026 revenue rose 2.4% to RMB1,343.6m, while attributable profit fell 57.3% to RMB20.8m and EPS declined to RMB0.07 from RMB0.20.

• Higher staffing, depreciation and operating costs, lower gross profit and increased associate losses weighed on earnings; patient volumes grew as nursing-care facilities began admitting patients.

Financial highlights

• Revenue was RMB1,343.6m versus RMB1,312.3m; cost of revenue rose 5.4% to RMB1,162.9m.

• Gross profit fell 13.4% to RMB180.7m; operating profit was RMB41.2m versus RMB75.0m, and profit before tax was RMB34.0m versus RMB70.4m.

• Attributable profit was RMB20.8m versus RMB48.7m; income tax expense decreased to RMB13.1m from RMB21.7m.

• Total comprehensive income was RMB3.7m versus RMB49.0m, including RMB17.2m of other comprehensive loss, mainly translation differences.

• Net finance income was RMB5.1m versus net finance costs of RMB4.3m; interest income rose to RMB11.3m from RMB1.4m.

Outlook and guidance

• H2 priorities include developing clinical specialties, strengthening multidisciplinary collaboration and improving care quality, efficiency and patient experience.

• Plans include expanding nursing care and integrating acute, rehabilitation and long-term care, while recruiting and retaining medical professionals and developing technology.

• Management plans to improve cost control, resource utilization and operational efficiency while pursuing prudent, compliant growth.

• Remaining IPO proceeds are expected to fund hospital expansion, medical equipment, smart-hospital upgrades and working capital under disclosed timetables through 2028.